The Substance Abuse and Mental Health Services Administration (SAMHSA) announces that it will hold a public listening session on October 1, 2016, to solicit feedback regarding the training requirements that have been stipulated in the Comprehensive Addiction and Recovery Act (CARA) (Pub.L. 114-198). The session will be held in Newark, NJ, to obtain direct public input from stakeholders on the training requirements.
On July 22, 2016 the Comprehensive Addiction and Recovery Act (CARA), was signed into law by President Obama. The new law authorizes prescribing privileges of buprenorphine in office-based settings by nurse practitioners (NPs) and physician assistants (PAs) for five years (until October 1, 2021). While at this moment there is no set date when NPs and PAs will be able to apply to receive a waiver to prescribe buprenorphine. SAMHSA is contemplating strategies on how to best implement this change seamlessly. SAMHSA will convene a meeting of the organizations listed in statute to discuss their existing training programs.